Ferrer

Europe's ambition to remain a global leader in sustainability must be matched by policies that enable responsible businesses to thrive. We are proud to have contributed to Unlocking Purpose-Driven Competitiveness in Europe, a new B Lab Europe report co-developed with more than 20 B Corps across 11 European countries. The report shows that purpose-driven businesses are already helping build a more resilient, innovative and sustainable economy. Yet structural barriers continue to limit their ability to scale. Its conclusion is clear: if Europe wants sustainability to become a source of long-term competitiveness, it must create the conditions for responsible businesses to succeed. Key recommendations include: 🔹 Governance frameworks that support long-term value creation 🔹 Public procurement that rewards verified impact 🔹 Better alignment between finance and impact-driven business models 🔹 Clear guidance on sustainability communications Europe already has purpose-driven businesses delivering impact. Now it needs policies that help them thrive. 📄 Read the report here: https://lnkd.in/e7cFsnks #BCorp #PurposeDrivenCompetitiveness #SustainableBusiness #EUPolicy

Ferrer and Prilenia are pleased to share that the first participant has been randomized in the PRECISE-HD confirmatory Phase 3 study of pridopidine, an investigational medicinal product taken as an oral capsule twice daily, in #Huntingtonsdisease (#HD). The first patient was randomized at the Hereditary Neurological Disease Centre, Kansas, under the supervision of William M. Mallonee, MD, FAAN. This milestone marks the start of participant enrolment, with several US sites now active and additional sites in Canada, the EU and the UK set to follow later this year. PRECISE-HD is designed to further evaluate the efficacy and safety of pridopidine and generate data to support regulatory evaluation. The approximately 400-participant, randomized, double-blind, placebo-controlled study will assess the effects of pridopidine on a range of clinical and functional outcomes relevant to people living with Huntington’s disease. #RareDisease

#OurActivity is about transforming science into solutions that change lives, delivering innovation aligned with our purpose and focused on addressing unmet medical needs in our therapeutic areas. In 2025, we continued to strengthen a strategic and balanced innovation pipeline, integrating the voice of patients throughout the process and working to ensure that our innovation reaches the people who need it most. In this video, Monica Pijoan shares how our R&D has patients at its centre and why improving people's lives remains the driving force behind everything we do. Discover more in our 2025 Sustainability Report: https://lnkd.in/eAGd7TBU

#CollectiveAction is about advancing social justice by working together to create positive, lasting change in the communities where we operate. In 2025, we continued to support social projects, strengthen partnerships and mobilise our people around initiatives that help tackle inequality and expand opportunities for those who need them most. In this video, Pol Villegas shares some of the progress we've made over the past year and the role collective action plays in achieving our purpose. Discover more in our 2025 Sustainability Report: https://lnkd.in/eAGd7TBU

#LiveablePlanet is about reducing our environmental impact and contributing to a healthier, more sustainable future through climate action and the protection of natural capital. In 2025, we continued to advance initiatives across decarbonisation, sustainable mobility and logistics, circular economy, water stewardship and biodiversity, helping transform both our operations and value chain. In this video, Rafa Abella shares some of the progress we've made over the past year and what still needs to be done. Discover more in our 2025 Sustainability Report: https://lnkd.in/eAGd7TBU

#GreatPeople is about creating the conditions for people to grow, thrive and make a meaningful impact in a culture based on trust and accountability. In 2025, we continued to advance initiatives that support development, leadership, inclusion, wellbeing and engagement across Ferrer, because we believe that our purpose starts with our people. In this video, Maria Junyent Freixenet shares some of the progress we've made over the past year. Discover more in our 2025 Sustainability Report: https://lnkd.in/eAGd7TBU

𝗧𝗵𝗲 𝗻𝘂𝗺𝗯𝗲𝗿𝘀 𝘀𝗽𝗲𝗮𝗸 𝗳𝗼𝗿 𝘁𝗵𝗲𝗺𝘀𝗲𝗹𝘃𝗲𝘀! Ferrer's 2025 #SustainabilityReport is the most tangible expression of our commitment to transparency and accountability, bringing together the key figures and milestones that shaped the past year. Behind every number is a deliberate effort to create measurable impact for people and the planet, and a commitment to turning our purpose into action. The figures in the video also reflect one of our core priorities as a company: reinvesting in the future. From advancing research to supporting social and environmental causes, we continue to demonstrate that business success should be measured not by what we keep, but by what we give back to society. 📊 Explore our impact in numbers and read the full report: https://lnkd.in/eAGd7TBU #FerrerForGood #Accountability #SocialJustice

Our 2025 #SustainabilityReport is now available. At Ferrer, we believe the purpose of business is not to maximise profits, but to solve the problems of people and the planet, generating profits in doing so. Our Sustainability Report reflects that conviction. It highlights the progress we've made throughout 2025, the challenges we continue to face and the actions we're taking to create positive impact. We know there is still a long way to go, and we remain committed to communicating our progress openly and honestly. We invite you to read the report and join us on this journey. 📖 Read the full report here: https://lnkd.in/eAGd7TBU #FerrerForGood #Accountability #SocialJustice

Progress in ALS is not driven by any one study, organisation or stakeholder alone. It is shaped by the collective efforts of researchers, healthcare professionals, patient advocates, caregivers and people living with the disease. At ENCALS 2026, we had the opportunity to hear from experts across the ALS community, share progress on our research programmes and contribute to important conversations about the future of ALS care and innovation. While people living with ALS continue to face significant challenges, the commitment to supporting them remains strong. Thank you to everyone who contributed to this year's meeting. Together, we can continue advancing understanding, challenging assumptions and helping to create a future with more options for people living with ALS. #ENCALS2026 #ALSResearch #RareDisease

Today, Ferrer and Prilenia can announce the initiation of the Huntington’s Disease study, PRECISE-HD. This confirmatory study, which has now commenced recruitment, will involve 400 participants across up to 75 sites globally, including in the US, EU, UK and Canada. Huntington’s disease is a progressive genetic condition that remains only partly understood, despite its profound impact on people living with the disease and their loved ones. With the PRECISE-HD study we will incorporate learnings from prior research and advice and input from the Huntington’s Disease patient and research community and regulatory authorities, who provide essential insights into the experiences of patients. Learn more: https://lnkd.in/edxWHASd This information relates to the conduct of the clinical trial and does not imply approval of the investigational product. More details: ClinicalTrials.gov NCT07609108